Browse by Title

Type here to filter the list

O
Optimal toxicity management
Favorite

Kate Young, MBBS, MA, MRCP, MD(Res) (she/her/hers) – Royal Marsden Hospital ### 1828461###Speaker###Consultant Medical Oncologist###Royal Marsden Hospital###
Speaker: Kate Young, MBBS, MA, MRCP, MD(Res) (she/her/hers) – Royal Marsden Hospital
### she/her/hers
Optimizing clinical trial designs by integrating tissue derived markers
Favorite

Yann-Alexandre Vano, MD PhD (he/him/his) – Hôpital Européen Georges Pompidou, AP-HP. Centre – Université Paris Cité, Paris, France ### 1927572###Speaker###Medical Oncologist###Hôpital Européen Georges Pompidou, AP-HP. Centre – Université Paris Cité, Paris, France###
Speaker: Yann-Alexandre Vano, MD PhD (he/him/his) – Hôpital Européen Georges Pompidou, AP-HP. Centre – Université Paris Cité, Paris, France
### he/him/his
Optimizing later line therapy selection
Favorite

Camillo Porta, MD (he/him/his) – University of Bari "A. Moro" ### 1828464###Speaker###Full Professor###University of Bari "A. Moro"###
Speaker: Camillo Porta, MD (he/him/his) – University of Bari "A. Moro"
### he/him/his
Tour #1 - Journey of Flavour - Johnnie Walker
Favorite
Optional Activities - Explore Edinburgh - Friday Evening
Favorite
Optional Activities - Explore Edinburgh - Saturday Evening
Favorite
Oral Abstract: Baseline circulating soluble factors as predictors of benefit from nivolumab in metastatic renal cell carcinoma (mRCC): additional multivariate analyses of the pooled translational NIVOREN GETUG-AFU26 population
Favorite

Lucia Carril Ajuria, MD (she/her/hers) – Institute Gustave Roussy /CHU St Pierre-CHU Brugmann ### 1589716###Lead Author###Chef de Clinique Adjoint###Institute Gustave Roussy /CHU St Pierre-CHU Brugmann###
Lead Author: Lucia Carril Ajuria, MD (she/her/hers) – Institute Gustave Roussy /CHU St Pierre-CHU Brugmann
### she/her/hers
Oral Abstract: Eosinophilic solid and cystic renal cell carcinoma : a rare new entity associated with TSC1/TSC2 genetic alteration and rare metastatic potential.
Favorite

Virginie Verkarre, MD PhD (she/her/hers) – APHP-Centre, Université de Paris-Cité, INSERM UMR970 ### 1927550###Lead Author###Pathologist, MD, PhD###APHP-Centre, Université de Paris-Cité, INSERM UMR970###
Lead Author: Virginie Verkarre, MD PhD (she/her/hers) – APHP-Centre, Université de Paris-Cité, INSERM UMR970
### she/her/hers
Oral Abstract: Health Related Quality of Life (HR-QOL) Measures in Renal Cell Carcinoma: Patient-reported relevance of items of the FKSI-19, EORTC QLQ-C30 and EQ-5D.
Favorite

Benjamin D. Mercier, BS (he/him/his) – City of Hope Comprehensive Cancer Center ### 1927551###Lead Author###Clinical Research Assistant I###City of Hope Comprehensive Cancer Center###
Lead Author: Benjamin D. Mercier, BS (he/him/his) – City of Hope Comprehensive Cancer Center
### he/him/his
Oral Abstract: Patients’ experiences on the course of treatment after partial nephrectomy or percutaneous cryoablation of small renal cell carcinoma - a cross-sectional multicenter study
Favorite

Theresa Junker, PhD – Research and Innovation Unit of Radiology ### 1853128###Lead Author###Postdoctoral researcher###Research and Innovation Unit of Radiology###
Lead Author: Theresa Junker, PhD – Research and Innovation Unit of Radiology
###